Search - tctmd.com

Displaying 221 - 240 of 318

Sort: Relevancy | Date

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

L.A. McKeown

December 05, 2012

News Conference News AHA 2012

Platelet Reactivity in Response to Prasugrel Depends on the Test

November 04, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News AHA 2012

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Jason Kahn

November 04, 2012

News Industry News

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

October 25, 2012

News Industry News

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

October 25, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

Presentation TCT 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

October 24, 2012

News Conference News TCT 2012

Presentations Examine Multiple Facets of Antiplatelet Agents

October 24, 2012

News Conference News TCT 2012

PARADOX: Smoking Enhances Effect of Clopidogrel, Prasugrel Unaffected by Smoking Status

October 23, 2012

Presentation TCT 2012

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

Presenter: Dirk Sibbing

October 22, 2012

Presentation TCT 2012

P2Y12 Inhibitors: Could Platelet Reactivity to Balance Between Bleeding and Ischemic Events

Presenter: Laurent Bonello

October 22, 2012

News Daily News

Un Estudio Avala ½ Dosis de Prasugrel en Pacientes de Poco Peso con EAC

October 18, 2012

News Daily News

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

October 18, 2012

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

News Daily News

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Jason Kahn

July 17, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

Advertisement

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Prasugrel y Ticagrelor Retrasan la Acción Antiplaquetaria en Pacientes Víctimas de un STEMI

Platelet Reactivity in Response to Prasugrel Depends on the Test

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

ARCTIC: Bedside Platelet Monitoring Fails to Help DES Patients

Low Responsiveness to Clopidogrel Predicts Stent Thrombosis, Heart Attack; but is Not Directly Linked to Death

8500+ Patient Trial Validates Association between High Platelet Reactivity and 1-Year Cardiovascular Outcomes at TCT 2012

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presentations Examine Multiple Facets of Antiplatelet Agents

PARADOX: Smoking Enhances Effect of Clopidogrel, Prasugrel Unaffected by Smoking Status

P2Y12 Inhibitors: Specific Agents for Specific Patient Cohorts? (STEMI, Diabetes, CKD, Prior Stroke, Etc.)

P2Y12 Inhibitors: Could Platelet Reactivity to Balance Between Bleeding and Ischemic Events

Un Estudio Avala ½ Dosis de Prasugrel en Pacientes de Poco Peso con EAC

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Las Directrices Elevan el Ticagrelor a la Categoría de Antiplaquetario de 1ª Línea contra la Angina Inestable

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content